XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Jun. 30, 2023 0.9        
Beginning balance at Jun. 30, 2023 $ 876        
Ending balance (in shares) at Sep. 29, 2023 0.9        
Ending balance at Sep. 29, 2023 $ 876        
Common stock, beginning balance (in shares) at Jun. 30, 2023   322.0      
Beginning balance at Jun. 30, 2023 10,964 $ 3 $ 3,936 $ (548) $ 7,573
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (685)       (685)
Employee stock plans (in shares)   2.0      
Employee stock plans (43)   (43)    
Stock-based compensation 77   77    
Foreign currency translation adjustment (38)     (38)  
Net unrealized gain (loss) on derivative contracts (45)     (45)  
Common stock, ending balance (in shares) at Sep. 29, 2023   324.0      
Ending balance at Sep. 29, 2023 $ 10,230 $ 3 3,970 (631) 6,888
Beginning balance (in shares) at Jun. 30, 2023 0.9        
Beginning balance at Jun. 30, 2023 $ 876        
Ending balance (in shares) at Mar. 29, 2024 0.9        
Common stock, beginning balance (in shares) at Jun. 30, 2023   322.0      
Beginning balance at Jun. 30, 2023 $ 10,964 $ 3 3,936 (548) 7,573
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (837)        
Common stock, ending balance (in shares) at Mar. 29, 2024   326.0      
Ending balance at Mar. 29, 2024 $ 10,121 $ 3 4,018 (636) 6,736
Beginning balance (in shares) at Sep. 29, 2023 0.9        
Beginning balance at Sep. 29, 2023 $ 876        
Ending balance (in shares) at Dec. 29, 2023 0.9        
Ending balance at Dec. 29, 2023 $ 876        
Common stock, beginning balance (in shares) at Sep. 29, 2023   324.0      
Beginning balance at Sep. 29, 2023 10,230 $ 3 3,970 (631) 6,888
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (287)       (287)
Employee stock plans (in shares)   2.0      
Employee stock plans 33   33    
Stock-based compensation 72   72    
Purchase of capped calls related to the issuance of convertible notes, net of tax (118)   (118)    
Foreign currency translation adjustment 58     58  
Net unrealized gain (loss) on derivative contracts 80     80  
Common stock, ending balance (in shares) at Dec. 29, 2023   326.0      
Ending balance at Dec. 29, 2023 $ 10,068 $ 3 3,957 (493) 6,601
Ending balance (in shares) at Mar. 29, 2024 0.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ 135        
Employee stock plans (16)   (16)    
Stock-based compensation 77   77    
Foreign currency translation adjustment (75)     (75)  
Net unrealized gain (loss) on derivative contracts (68)     (68)  
Common stock, ending balance (in shares) at Mar. 29, 2024   326.0      
Ending balance at Mar. 29, 2024 $ 10,121 $ 3 4,018 (636) 6,736
Beginning balance (in shares) at Jun. 28, 2024 0.2        
Beginning balance at Jun. 28, 2024 $ 229        
Ending balance (in shares) at Sep. 27, 2024 0.2        
Ending balance at Sep. 27, 2024 $ 229        
Common stock, beginning balance (in shares) at Jun. 28, 2024 343.0 343.0      
Beginning balance at Jun. 28, 2024 $ 10,818 $ 3 4,752 (712) 6,775
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 493       493
Employee stock plans (in shares)   3.0      
Employee stock plans (64)   (64)    
Stock-based compensation 84   84    
Foreign currency translation adjustment 121     121  
Net unrealized gain (loss) on derivative contracts 191     191  
Common stock, ending balance (in shares) at Sep. 27, 2024   346.0      
Ending balance at Sep. 27, 2024 $ 11,643 $ 3 4,772 (400) 7,268
Beginning balance (in shares) at Jun. 28, 2024 0.2        
Beginning balance at Jun. 28, 2024 $ 229        
Ending balance (in shares) at Mar. 28, 2025 0.2        
Ending balance at Mar. 28, 2025 $ 229        
Common stock, beginning balance (in shares) at Jun. 28, 2024 343.0 343.0      
Beginning balance at Jun. 28, 2024 $ 10,818 $ 3 4,752 (712) 6,775
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,607        
Distribution in connection with the Separation $ 546        
Common stock, ending balance (in shares) at Mar. 28, 2025 349.0 349.0      
Ending balance at Mar. 28, 2025 $ 5,177 $ 3 4,642 11 521
Beginning balance (in shares) at Sep. 27, 2024 0.2        
Beginning balance at Sep. 27, 2024 $ 229        
Ending balance (in shares) at Dec. 27, 2024 0.2        
Ending balance at Dec. 27, 2024 $ 229        
Common stock, beginning balance (in shares) at Sep. 27, 2024   346.0      
Beginning balance at Sep. 27, 2024 11,643 $ 3 4,772 (400) 7,268
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 594       594
Employee stock plans (in shares)   2.0      
Employee stock plans 36   36    
Stock-based compensation 77   77    
Foreign currency translation adjustment (100)     (100)  
Net unrealized gain (loss) on derivative contracts (133)     (133)  
Common stock, ending balance (in shares) at Dec. 27, 2024   348.0      
Ending balance at Dec. 27, 2024 $ 12,117 $ 3 4,885 (633) 7,862
Ending balance (in shares) at Mar. 28, 2025 0.2        
Ending balance at Mar. 28, 2025 $ 229        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 520       520
Distribution in connection with the Separation (7,618)   (307) 546 (7,857)
Employee stock plans (in shares)   1.0      
Employee stock plans 5   5    
Stock-based compensation 59   59    
Dividends to shareholders (4)       (4)
Foreign currency translation adjustment 24     24  
Net unrealized gain (loss) on derivative contracts $ 74     74  
Common stock, ending balance (in shares) at Mar. 28, 2025 349.0 349.0      
Ending balance at Mar. 28, 2025 $ 5,177 $ 3 $ 4,642 $ 11 $ 521